Cargando…
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Following the breakthrough of numerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in recent months and the incomplete efficiency of the currently available vaccines, development of more effective vaccines is desirable. Non-integrative, non-cytopathic and non-inflammatory l...
Autores principales: | Vesin, Benjamin, Authié, Pierre, Blanc, Catherine, Fert, Ingrid, Noirat, Amandine, Le Chevalier, Fabien, Wei, Yu, Ku, Min-Wen, Nemirov, Kirill, Anna, François, Hardy, David, Planchais, Cyril, Mouquet, Hugo, Guinet, Françoise, Charneau, Pierre, Majlessi, Laleh, Bourgine, Maryline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865670/ https://www.ncbi.nlm.nih.gov/pubmed/36679857 http://dx.doi.org/10.3390/vaccines11010012 |
Ejemplares similares
-
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
por: Nemirov, Kirill, et al.
Publicado: (2023) -
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
por: Vesin, Benjamin, et al.
Publicado: (2022) -
Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice
por: Ku, Min‐Wen, et al.
Publicado: (2021) -
Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine
por: Douguet, Laëtitia, et al.
Publicado: (2023) -
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
por: Nemirov, Kirill, et al.
Publicado: (2023)